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1. Introduction  
Proteins have native functional states but can also form amyloid fibrils (Fowler et al .,2007, 
Maji et al., 2009, Dobson et al., 2003). In the amyloid state, proteins are denaturated and 
aggregated with -sheet-rich structures. Accumulation of amyloids can result in protein 
amyloidosis, which has attracted much attention. Amyloidosis is associated with many 
serious neurodegenerative diseases, such as Alzheimer’s disease (Sipe et al., 1992), dialysis-
related amyloidosis (Rochet et al., 2000), prion disease (Prusiner, 1998), and type II diabetes 
(Ahmad et al., 2004). Consequently, it is important to clarify the mechanism of amyloidosis, 
so that it can be inhibited or controlled. Amyloid structures have been analyzed by various 
methods including nuclear magnetic resonance (NMR) spectroscopy, electron microscopy, 
X-ray spectroscopy and Fourier transform infrared (FTIR) spectroscopy. Theoretical 
calculations of amyloidosis have also been conducted (Miller et al., 2010).  
Protein amyloidosis is affected by environmental conditions such as the temperature 
(Kusumoto et al., 1998), pH (Petkova et al., 2004), and ionic strength (Zidar et al., 2011), and by 
nucleation (Kanji et al., 2008). Because amyloidosis occurs at the cell surface, the interaction 
between the protein and cell interface is also important (Xu et al., 2005). Therefore, the 
amyloidosis of proteins can be controlled by manipulating the environmental conditions. 
However, it has been reported that artificial additives, such as metal ions (Chanki et al., 2007), 
peptides (Suzuki et al., 2010), sugars (Anubhav et al., 2004) and nanoparticles (Saraiva et al., 
2010), can alter the environmental conditions and affect amyloidosis. 
Because amyloidosis occurs in vivo, the molecules on the cell surfaces are of interest as 
additives to control amyloidosis. It has been reported that protein amyloidosis with 
Amyloid beta (A) (Alzheimer’s disease) (McLaurin et al., 1996), 2-microglobulin (dialysis-
related amyloidosis) (Bourgault et al., 2011), and prion protein (Pan et al., 2002) formation is 
affected by interactions with glycosaminoglycans (GAGs) on the cell surfaces. This affects all 
these proteins, even though they have different amino acid sequences and native protein 
structures. GAGs are long unbranched polysaccharides of repeating disaccharide subunits 
of hexosamines (glucosamine and galactosamine) and uronic acid (glucuronic acid and 
iduronic acid) (Rudd et al., 2010). Well-known GAGs are heparin, chondroitin sulfate, 
keratin sulfate, dermatan sulfate and hyaluronic acid. Most GAGs are highly sulfonated. 
The interaction of proteins with GAGs is important in amyloidosis, but it is difficult to 
analyze the detail of this interaction because GAGs have complex structures and high 
molecular weights.  
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Synthetic model molecules are useful to clarify the biological function of GAGs. Suda et al. 
used a synthetic pentasaccharide that bound antithrombin III to study the function of 
heparin, and produced a biochip with the synthetic GAG (Suda et al., 1993, 2006). Although 
a number of studies have been reported the compositions of oligosaccharides in GAGs (Jose 
et al., 2006) and syntheses for GAGs (Jeroen et al., 2005), these investigations did not 
consider the effect of the molecular weight of GAGs even though they have high molecular 
weights (5,000–30,000). It is difficult to account for the physical properties and multivalent 
effects of saccharides within the oligosaccharide following polymerization. 
We previously investigated the biological functions using multivalent glycoclusters, and 
applied these results to production of materials (Miura et al., 2007). Multivalency is 
important in the biological function of saccharides because it increases the affinity 
between the saccharides and proteins when the saccharide interaction is weak (Mammen 
et al., 1998). Glycoclusters include glycopolymers, glycodendrimers (Aoi et al., 1995), and 
glyco-thin layers (Lang et al., 2008), which all increase the protein–saccharide 
interactions. Among these types of glycoclusters, glycopolymers with pendant 
saccharides showed the strongest amplification effect. In this work, we investigated the 
interaction between GAG models and A to examine the function of GAGs in 
amyloidosis. The saccharide used was 6-sulfo-N-acetyl-glucosamine (6S-GlcNAc), which 
is frequently present in heparin (Uchimura et al., 1998, Sasaki et al. 2003). An artificial 
glycocluster of glycopolymer and a glyco-thin layer was prepared, and its interaction 
with A was investigated. 
2. Inhibition of aggregation of amyloid  with sulfonated glycopolymers 
In this section, synthetic glycopolymers were produced to mimic GAGs and used to 
investigate control of aggregation of A. Although the saccharide–protein interaction is 
generally weak, the glycopolymer increases this interaction through its multivalency. The 
multivalency can be easily altered by adjusting the initial feed ratio in the polymerization. It 
is difficult to complete the total synthesis of GAGs. In the present study, GAGs were 
mimicked using a glycopolymer (Figure 1) that was an acrylamide derivative of the 
saccharide 6S-GlcNAc.  
 
 
Fig. 1. The GAGs in amyloidosis and this chapter’s study. (a)The design of GAGs mimic 
compounds. (b) The role of GAGs in amyloidosis. 
The monomer was synthesized from N-acetyl-glucosamine (GlcNAc) by modification with 
p-nitrophenyl-GlcNAc. The obtained acrylamide derivative was polymerized using a radical 
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initiator. The saccharide contents were varied in the copolymerization of glycopolymer and 
acrylamide. The sugar contents of the polymers were 10–100 %, and the molecular weights 
of the polymers were in the order of 105. The reference polymers were the glycopolymer of 
GlcNAc without sulfonated GlcNAc, polyacrylamide, and monomeric 6S-GlcNAc (Figure 2). 
The interactions of A with the glycopolymers were evaluated by a Thioflavin T (ThT) 
fluorescence assay, observation of the morphology by atomic force microscopy (AFM), 
circular dichroism (CD) spectroscopy, and in vitro neutralization of an MTT assay. The 
protein used in this section was A(1-42). 
 
 
Fig. 2. Chemical structure of GAGs mimic polymers used in section 2 
2.1 ThT fluorescence assay of A aggregation in the presence of glycopolymers 
The aggregation of A was monitored with ThT in the presence of different glycopolymers 
(Figure 3). ThT binds to -sheet aggregates. The ThT fluorescence of A in the absence of 
any additive increased for 8 h to a final fluorescence of 100. When the monomeric sulfonated 
GlcNAc (pNP-6S-GlcNAc, 1) was added to the A solution, no remarkable change was 
observed in the time-course ThT fluorescence. To improve the weak interaction between 6S-
GlcNAc and A, multivalent compounds were then investigated. The addition of 
glycopolymers of 6S-GlcNAc (3–6) resulted in inhibition of A aggregation. Interestingly, 
the inhibition effect was dependent on the sugar content of the polymer. While the 
glycopolymers with low sugar contents, 5 (28 %) and 6 (12 %), showed strong inhibition of 
A aggregation, the glycopolymers with high sugar contents, 3 (100 %) and 4 (65 %), did not 
show strong inhibition. The glycopolymer of GlcNAc without the sulfonate did not change 
the time-course of ThT fluorescence, and polyacrylamide without the saccharide or 
sulfonate did not inhibit aggregation.  
These data suggest that the sulfonate in the glycopolymer is essential for A aggregation, 
and that the level of inhibition is also related to the sugar content the glycopolymer. This 
indicates that the degree of sulfonation in GAGs and their physical properties are important 
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in the formation of A deposits. It has been reported that GAGs induce and also inhibit the 
aggregation of A, which is related to the degree of sulfonation and the physical properties. 
 
 
Fig. 3. Time-course of the fluorescence change in ThT at 37°C with A (1-42) and sugar 
additives (a) with sulfonated GlcNAc of 1, 3, 4, 5, and 6, (b) with polymers of 2 and 7. The 
concentration of A and sugar was 20 M and 200mM  
2.2 Changes in morphology and neutralization of A by glycopolymers 
The morphology of aggregated A was observed in the presence of glycopolymers by AFM 
(Figure 4). A readily formed amyloid fibrils 15–50 nm wide, 5–15 nm high, and a few 
micrometers in length. While the addition of monomeric saccharide (1) reduced the size of 
the amyloid fibrils, fibril formation still occurred. The addition of the glycopolymers with 
6S-GlcNAc acid (3–6) changed the morphology. The addition of the glycopolymer with a 
low sugar content (5 and 6) changed the A into spheres with diameters of 10–250 nm. By 
contrast, the glycopolymers with a high sugar content (3 and 4) did not inhibit fibril 
formation, and the fibrils increased in size (width 60–300 nm). These morphology 
observations suggest that A interacted strongly with the sulfonated glycopolymers. These 
changes were interesting because of the relationship of A’s morphology to cytotoxicity 
(Hoshi et al., 2003, Hardy et al., 2002, Kayed et al., 2003). The cytotoxity Arelates the 
amount of accumulated Aand the morphology, where the oligomeric Aswith nm order 
and round morphology has been reported to show the cytotoxity. The results of AFM 
observation suggest that the development of Alzheimer’s disease is related to the degree of 
sulfonation of GAGs. Control of A‘s morphology was investigated with specific sulfonated 
glyco-clusters in a later section.  
The neutralization of the cytotoxicity of A was investigated using HeLa cells. When the 
cells were incubated with A, A reduced the cell survival rate by about 50 %, but the 
addition of sulfonated glycopolymer (6) restored the cell survival rate. Glycopolymer 6 
alone did not show any cytotoxicity. The interaction between Aand the the glycopolymer 
ihibitied the accumulation or oligomer formation. Therefore, this glycopolymer, and 
perhaps GAGs, could safely be used as polymer medicines.  
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Fig. 4. AFM observations of A(1-42) (a) without glycopolymer, (b) in the presence of 1, (c) 3 
and (d) 6.  
3. The inhibition of amyloid  aggregation by the glycopolymer with precise 
molecular weight via living radical polymerization  
In section 2, glycopolymers with 6S-GlcNAc were shown to bind to A, inhibit A 
aggregation, and neutralize the cytotoxicity of A. Because of the structural diversity of 
GAGs, the glycopolymer library is useful to analyze the function of GAGs in A 
amyloidosis. This could be used to develop a glycopolymer that acts as a better inhibitor of 
A aggregation. Although it is difficult to analyze the GAGs, the fabrication of 
glycopolymers is easily achieved by facile radical polymerization. Other polymerization 
techniques, such as living radical polymerization and graft polymerization, can also be used 
for this. In this section, a library of glycopolymers with different molecular weights and 
saccharide structures was prepared to analyze the interaction of Awith various 
glycopolymer. Because natural GAGs are copolymer with hexosamines and uronic acids, the 
glycopolymers were synthesized using 6S-GlcNAc and glucuronic acid (GlcA).  
3.1 Glycopolymer library via living radical polymerization 
The glycopolymer library was designed using acrylamide derivatives of 6S-GlcNAc and 
GlcA (Figure 5). The glycopolymers with 6S-GlcNAc were polyanionic, and were mimics of 
heparin, while the glycopolymers with GlcA were mimics of hyaluronic acid. The 
terpolymer of 6S-GlcNAc and GlcA was better mimic of general GAGs in terms of the sugar 
structure. The sugar contents of the polymers were set at about 10 % based on the results 
from section 2.1, and the monomer structures were investigated.  
 
 
Fig. 5. Chemical structure and molecular weight (Mn) of GAGs mimic polymers in 
section 3.  
Because the molecular weight of GAG affects its biological function, the impact of the 
molecular weight of the glycopolymer was also investigated. Low molecular GAGs have 
been reported to show therapeutic effects (Walzer et al., 2002, Zhu et al., 2001) in protein 
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amyloidosis. Glycopolymers with various molecular weights were synthesized by reversible 
addition–fragmentation chain transfer (RAFT) living radical polymerization (Moad et al 
2008). The living radical polymerization can be used to synthesize well-defined polymers 
with various molecular weights. Compared with other methods like atom transfer radical 
polymerization (ATRP), it is easier to synthesize bulky complicated monomers using RAFT 
living radical polymerization. Dithioesters and trithiocarbonates can be used as reagents in 
RAFT polymerization. In this study, (thiobenzoyl)thioglycolic acid was used as the RAFT 
reagent in glycopolymer syntheses.  
Glycopolymers with 6S-GlcNAc (10–12), GlcA(13–15), and terpolymer (16–18) were 
synthesized, and the molecular weights of these polymers were in the order of 105 (10, 13, 
and 16), 104 (11, 14 and 17) and 103 (12, 15, and 18) (Figure 5).  
 
Sample kn (s-1) ke (L mol-1 s-1) 
A(control) 1.3 ×10-6 3.4 
8 1.4 × 10-6 3.7 
10 7.3 ×10-9 6.6 
11 2.5 × 10-8 5.9 
12 5.1 × 10-10 7.9 
9 3.4 × 10-6 3.0 
13 4.2 × 10-6 2.5 
14 2.5 × 10-6 4.2 
15 6.7 × 10-6 2.5 
16 1.3 × 10-6 4.3 
17 6.7 × 10-7 3.4 
18 6.8 × 10-7 3.1 
Heparin 3.1 × 10-6 3.7 
Hyaluronic acid 1.5 × 10-6 3.4 
Table 1. Nucleation and elongation rate constants calculated by fitting ThT data.  
The protein A(1-40) was used to analyze the inhibition effect and kinetics. A(1-40) is the 
main component of amyloid deposits, and has lower ability to aggregate than A(1-42). 
Because A(1-40) is less likely to aggregate, the amyloid fibril formation was measured with 
fast shaking (400 rpm) after monomerization by hexafluoro-2-propanol.  
3.2 Kinetic analyses of the inhibition of A aggregation in the presence of 
glycopolymers 
Aggregation of A(1-40) was monitored in detail using its ThT fluorescence, which showed 
a sigmoidal curve (Figure 6). The addition of glycopolymers changed the time-course of ThT 
fluorescence. The glycopolymers with 6S-GlcNAc (10–12) extended the lag phase, which is 
the time taken for the fluorescence to increase initially, and the final fluorescence intensity 
was lower than that of control. However, the glycopolymers with GlcA (13–15) did not 
change the lag phase, which suggests these polymers had a weak interaction with A The 
ter-glycopolymer with both of 6S-GlcNAc and GlcA showed the best inhibition of A 
aggregation. The level of inhibition was largely dependent on the sugar structure.  
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Fig. 6. The time courses of aggregation and the secondary structures of A. (a) Time course 
of fibril formation with 400 rpm shaking at 37°C. The concentrations of A and sugar were 
23 and 200M. The sugar additives were poly(AAm/6S-GlcNAc)(12), poly(AAm/GlcA) (15) 
and poly(AAm/6S-GlcNAc/GlcA) (18). (b) The CD spectra of A in the presence of 
glycopolymers (12, 15 and 18).  
The level of inhibition was also dependent on the molecular weight of the polymer. The 
final fluorescence intensity changed with the molecular weight of the polymer even if the 
sugar content was the same. Glycopolymers with lower molecular weights produced a 
lower fluorescence intensity and the longer lag phase than glycopolymers with higher 
molecular weights. 
The aggregation properties were analyzed in detail by fitting of the fluorescence curve. The 
aggregation of A was analyzed using the processes of nucleation and elongation of the 
amyloid as follows:  
 nnM P   (nucleation process, kn) 
 1n nM P P     (elongation process, ke)   
where M and P are the monomeric and polymeric peptides, respectively. The kinetics data are 
summarized in Table 1. The results were analyzed in terms of the nucleation (kn) and 
elongation (ke) rate constants compared with the control. The glycopolymers with 6S-GlcNAc 
showed smaller kn and larger ke in comparison to the glycopolymers with GlcA, which 
induced larger kn and smaller ke. The 6S-GlcNAc monomer inhibited the nucleation of A, and 
the GlcA unit inhibited the elongation of the fibril. Among the glycopolymers, the terpolymer 
with both 6S-GlcNAc and GlcA showed the best inhibition of A aggregation and had the 
smallest kn and moderate ke. The effect of the molecular weight on A aggregation was 
analyzed using the kinetic parameters. With the 6S-GlcNAc polymer, the polymer with lower 
molecular weight had a smaller kn, which gave better inhibition of nucleation. With the 
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glycopolymer of both 6S-GlcNAc and GlcA, that with the lowest molecular weight was the 
best inhibitor (18). The molecular weight of a polymer affects various physical properties such 
as mobility, and low molecular weight polymers should have better binding to A. These 









Aggregate Fibril Fibril, Globule 
Pattern Globule  
Fibril Width 8-12nm 8-12nm  
 Length 1-2m 1-2m  
 Height 4-6nm 4-6nm  
Globule Height 7-9nm 10-20nm 
 Diameter 200-500nm 500-600nm 
Table 2. Aggregate patterns and sizes of A (1–42) on 19, 20 and 21. 
3.3 The conformation and morphology of A aggregation in the presence of various 
glycopolymers 
The AFM results were consistent with the ThT assay. The A aggregates without additives 
formed amyloid fibrils that were 1–3.5 m long, 160–230 nm wide, and 15–45 nm high. The 
A fibrils in the presence of the glycopolymer with 6S-GlcNAc (12) were 0.19–2.0 m long, 
110–180 nm wide, and 1–8 nm high. The A fibrils in the presence of the terpolymer (18) 
were 0.10–1.7 m long, 80–120 nm wide and 1.5-4.0 nm high (Table 2).  
The glycopolymer additives induced a specific conformation in A(Figure 7). A(1–40) 
without additives showed a -sheet structure with a negative Cotton effect around 220 nm 
in the CD spectra. The glycopolymer with 6S-GlcNAc gave a -sheet structure, and the 
Cotton effect was smaller than for the control A. With the ter-glycopolymers, the spectra 
showed broad negative Cotton effects with weak intensity. Interestingly, the glycopolymers 
with GlcA induced a different conformation, with the CD spectra showing negative Cotton 
effects around 208 nm and 220 nm, which suggests a partial -helical structure.  
 
 
Fig. 7. (a) Chemical structures of glyco-cluster and (b) the schematic illustration of the glyco-
cluster at the interface. 
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The conformation of A was also examined with addition of the natural GAGs  heparin 
(containing 6S-GlcNAc) and hyaluronic acid (containing GlcA). The addition of heparin 
induced a -sheet structure with a negative Cotton effect at 218 nm, which was consistent 
with the CD spectra in the presence of the 6S-GlcNAc glycopolymer. The addition of 
hyaluronic acid induced a broad negative Cotton effect at 208 nm, which suggests the 
conformation is not -sheet. When comparing the sulfonated GAGs like heparin, the roles of 
uronic acid and hyaluronic acid were not considered because of their weak interactions. If 
the polyvalent uronic acid or hyaluronic acid can operate as a molecular chaperon in 
amyloidosis, they will be useful bioactive compounds.  
3.4 Mechanism of inhibition of A aggregation 
Because the sulfonic acid in the GlcNAc was essential to inhibit A aggregation, this 
indicates the electrostatic interaction was the driving force behind the inhibition. Both A(1–
40) and A(1–42) have a net negative charge, but the proteins of A also contained cationic 
residues (Arg15, His6, His13, His14, Lys16, and Lys28). The anionic region of 13-HHQK-16 
was considered to play an important role, and the HHQK region has been reported to be 
important in determining the conformation of A Giulian et al. 1998).  
The sugar content of the polymer and the molecular weight effect were interesting for 
molecular design of an inhibitor. The glycopolymers of 6S-GlcNAc with a high sugar 
contents did not inhibit A aggregation. The conformation of this glycopolymer was stiff 
because of the bulky side chain of the polymer, which weakened the interaction with A. 
The cluster of anionic groups also inhibited the interaction because of electrostatic 
repulsion that occurred with the net negative charge of A. The role of GlcA was not 
clear but it provided the hydrogen bonding section and inhibited elongation of the 
fibrils.  
In this section, the effects of the glycopolymer, GAGs, and saccharides were investigated 
using the glycopolymer technique. The glycopolymer approach clearly showed the role of 
each saccharide, where sulfonated GlcNAc inhibited nucleation and induced fibril 
formation and -sheet formation, and uronic acid induced formation of a partial -helical 
structure. The library of glycopolymers with various molecular weights indicated the 
importance of the physical and chemical properties of GAGs, and suggested low molecular 
weight polymers were better for inhibition of A aggregation than high molecular weight 
polymers.  
4. The control of A amyloidosis with precise manipulation of the  
glyco-interface 
In section 2 and 3, sulfonated GlcNAc was determined to be a key monomer for A 
aggregation and protein amyloidosis. The results showed the effect a glycopolymer mimic 
of a GAG had on the amyloidosis was based on the interaction between A and sulfonated 
GlcNAc or A and sulfate group. We investigated the control of amyloidosis of A by 
manipulating the glyco-cluster interface with 6S-GlcNAc. The experiments were conducted 
on a gold interface for interaction analysis by surface plasmon resonance (SPR), FTIR, and 
AFM. The protein used was A(1–42), which can have various morphologies because of its 
self-assembly properties.  
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4.1 Molecular design of the glyco-interface 
Self-assembled monolayers (SAMs) of 6S-GlcNAc were prepared for fabrication of the 
glyco-cluster interface. An alkyl-disulfide with an acetylenyl group was modified via click 
chemistry, because an alkyl-disulfide with an oligoethylene glycol has been shown to be 
bioinert to inhibition of protein adsorption by non-specific interaction (Kolb et al. 2001) 
(Figure 8). Glyco-clusters with 6S-GlcNAc were synthesized using hydroxyl-benzene 
templates, and glyco-clusters with mono- (19), di- (20) and tri- (21) valent 6-S-GlcNAc with 
an azide-group were also synthesized. To modify the substrate, the reactive functional 
surface was prepared using SAMs. The alkyl-disulfide with an acetylene group was 
synthesized, and mixed SAMs were prepared using the alkyl-disulfide with acetylene and 
oligoethylene groups on the gold substrate. The ratio of the acetylene terminal was 20 %. 








Fig. 8. (A) Time courses of RU change on (a) no-sugar SAM, (b) 19, (c) 20 and (d) 21.  (B) Hill 
plot analysis using the RUeqmax on (a) 19, (b) 20 and (c) 21. 
The glyco-cluster of 6S-GlcNAc was prepared on the gold substrate. Gold substrates have 
advantages in biological analyses for surface plasmon resonance (SPR), quartz crystal 
microbalance (QCM), and electrochemistry. The interaction between 6S-GlcNAc and A was 
analyzed by SPR. The amount of bound A(1–42) (RUmax) changed with the valency, and for 
the different valency glycoclusters was in the order mono- (19)<<tri- (21)<di-valent (20). 
This suggests that multivalency is important for A binding to the glycocluster. The amount 
of A bound to the substrate was plotted to calculate the binding constants. The SPR results 
for the glycoclusters and A were fitted using a Hill plot, not by a Langmuir plot. The 
multivalent binding was quantitatively analyzed as follows: 
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where n and KD represent the Hill coefficient (cooperativity) and apparent binding constant, 
respectively. The equilibrium constants from the SPR results were 1.49 x 10-4, 1.16 x 10-5 and 
1.89 x 10-5 M for the mono-, di- and tri-valent saccharides, respectively. The Hill coefficients 
indicated the binding ratios (sugar/A) of the mono-, di-, and tri-valent glycoclusters were 
2:1, 1:1 and 1:1, respectively. This shows that multivalent binding is essential even for the 
monovalent cluster of 19 (binding with an adjacent sugar). The multiple sugar binding was 
accomplished by the two sugars binding to 13-HHQK-16 or to 13-HHQK-16 and Lys28. 
4.2 The morphology of A on the sugar interface 
The morphology on the glyco-substrate was investigated by AFM (Figure 9). Interestingly, 
the morphology of A was dependent on the type of glyco-cluster at the interface. The 
results are summarized in Table 2. When A(1-42) was incubated on the monovalent 6S-
GlcNAc (19), fibrils formed that were 4–6 nm high, 8–12 nm wide, and 1–2 m long. For di-
valent 6S-GlcNAc (20), both fibrils and spherical aggregates were observed. Furthermore, 
the incubation of A with trivalent 6S-GlcNAc (21) induced formation of only the spherical 
aggregates with inhomogeneous sizes. The spheres were a mixture of those 10–20 nm and 














Fig. 9. Morphologies observed by AFM with 6S-GlcNAc glyco-cluster of (a) monovalent (19), 
(b) divalent (20) and (c) trivalent (21). 
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The AFM observation of the glycocluster substrate suggested that A(1–42) had a tendency 
to form fibrils with the low valency 6-S-GlcNAc, and spherical aggregates with higher 
valency glycoclusters. The densely packed sulfonated or acidic sugars induced a strong 
morphological change in the A(1-42) aggregates. The morphological change of the amyloid 
aggregates from fibrils to spheres is consistent with the report of Ban et al.(Ban et al., 2006). 
The valency of the sulfonated GlcNAc determined the affinity to A, which induced specific 
morphologies and secondary structures. 
The secondary structure of A was measured on the glyco-cluster interface by FTIR in the 
amide region. The amide I band (C=O stretching) at 1670 cm-1 was the main peak in all 
cases, and corresponded to a -turn or unknown structure. The band at 1632 cm-
1 indicated an antiparallel -sheet structure, which was dependent on the valency of 6S-
GlcNAc. Remarkably, that band was the least intense in the spectrum of the trivalent 
interface (21), and the strongest in the spectrum of the monovalent interface (19). Taking 
into account the AFM observations, these results indicated that the fibrils on 19 had 
predominantly -sheet structure and the spheres on 21 had little -sheet structure. The 
strong binding of A to the 6S-GlcNAc interface suppressed the interaction with each 
peptide, which reduced the content of -sheet structure on 21. The secondary structure 
revealed that the structure with anti-parallel -sheet resulted in the fibril formation, and 
that with less -sheet structure resulted in the spheres. The negatively charged surface 
also contributed to the formation of the spherical morphology because of the electrostatic 
repulsion.  
The cytotoxicity of A(1–42) to HeLa cells was evaluated by MTT assay on the substrate. 
The cell viabilities with A(1–42) on the mono- (19), di- (20) and tri-(21) valent 
glycoclusters were 104 %, 84 %, 76 %, respectively. These results indicate that the 
cytotoxicity of A(1–42) varied because of the aggregation process. Aggregation of A(1-
42) on the trivalent glycocluster of 6S-GlcNAc formed globular objects, where the small 
spherical aggregates have been reported to show the high cytotoxity.  Though the size of 
the aggregates were much smaller than that of toxic oligomers (Hoshi et al 2003, Hardy et 
al 2002, Kayed et al 2003), the observed globular objects on trivalent 6S-GlcNAc had 
similar round morphology and had the high cytotoxicity. By contrast, aggregation on 
monovalent 6-S-GlcNAc showed no cytotoxicity. It has been reported that the spherical 
A exhibit strong cytotoxicity.  
The specific morphology of A was induced by the glycocluster on the substrate, which 
affect the secondary conformation, morphology and finally the cytotoxicity.  
5. Conclusion 
These studies using artificial glycoclusters revealed the role of sugars in GAGs in 
amyloidosis. Inhibition and control of amyloidosis of As was accomplished using 
glycoclusters of glycopolymers and a glycointerface with 6-sulfo-GlcNAc. The glycopolymer 
with 6-sulfo-GlcNAc inhibited the aggregation of A(1–40) and A(1–42). The appropriate 
valency of the polymer was essential to aggregation. The glycopolymers of 6-sulfo-GlcNAc 
with low sugar contents efficiently inhibited the A aggregation and neutralized its 
cytotoxicity. Kinetic analyses indicated that the sulfonated GlcNAc inhibited the nucleation, 
and that GlcA of uronic acid inhibited the fibril elongation. The molecular weight of the 
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polymers was also important, and the glycopolymer with a low molecular weight provided 
strong inhibition. The low molecular weight glycopolymer with both 6-sulfo-GlcNAc and 
GlcA showed the strongest inhibition.  
With specific glycocluster interfaces, the amyloidosis of A was dependent on the valency 
and the distance of the 6-sulfo-GlcNAc. High valent 6-sulfo-GlcNAc showed stronger 
interaction with A than mono valent 6-sulfo-GlcNAc. The dense tri-valent 6-sulfo-GlcNAc 
induced formation of spheres of A with less -sheet structure than with the other valencies 
of 6-sulfo-GlcNAc, and this structure showed cytotoxicity. By contrast, the non-dense 
monovalent saccharide induced fibril formation with a -sheet-rich structure without 
cytotoxicity.  
It is difficult to investigate the function of GAGs because of their complex structures, and 
this method using glycoclusters can be used to clarify their functions. In this investigation, 
only 6-sulfo-GlcNAc was used as a representative sugar of GAGs. Although wild type 
GAGs contain various and complicated sulfonated saccharides, this study of GAGs mimics 
provides useful information on the GAGs functions using precise control of the 6-sulfo-
GlcNAc cluster. To extend on this, glycocluster of other sulfonated saccharides are being 
synthesized in our laboratory. 
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